Aclaris Therapeutics, Inc.
Pharmaceutical company · Wayne, Pennsylvania, United States · Nasdaq: ACRS
Aclaris Therapeutics, Inc. is a pharmaceutical company headquartered in Wayne, Pennsylvania, United States. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker ACRS. It has reported private securities offerings to the US SEC, most recently $80 million sold in a notice filed in 2024.
Aclaris Therapeutics at a glance
What does Aclaris Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $80 million sold (2024).
Frequently asked questions about Aclaris Therapeutics
Where is Aclaris Therapeutics headquartered?
Aclaris Therapeutics, Inc. is headquartered in Wayne, Pennsylvania, United States.
What does Aclaris Therapeutics do?
Aclaris Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Aclaris Therapeutics a public company?
Yes. Aclaris Therapeutics, Inc. trades on Nasdaq under the ticker ACRS.
When was Aclaris Therapeutics founded?
The earliest incorporation on record for Aclaris Therapeutics, Inc. is in 2012, according to public company registers.
Similar companies
- Avalo Therapeutics, Inc.Wayne, Pennsylvania, United States
- Palvella Therapeutics, Inc.Wayne, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.